相关实验视频

Updated: May 11, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

病例报告:胸部瘤作为F-Choline PET/CT和F-FDG PET/CT的诊断陷

Karim Amrane^1,2, Coline Le Meur³, Pierre Alemany⁴

¹Department of Oncology, Regional Hospital of Morlaix, Morlaix, France.

Frontiers in oncology

|October 23, 2024

概括

在PET/CT扫描上,中神经瘤可以模仿癌症. 在中间体中增加18F-FDG和18F-胆PET/CT的吸收可能表明了神经瘤,而不是转移.

科学领域:

在瘤学瘤学.
放射学放射学是一门学科.
核医学是一种核医学.

背景情况:

中质量可能会带来诊断上的挑战.
使用像18F-FDG和18F-Choline这样的标记物的正子发射断层扫描/计算机断层扫描 (PET/CT) 对于诊断和分期癌症至关重要.
胸部神经瘤是一种罕见的神经性瘤,可以发生在中.

研究的目的:

为了突出介质腺素瘤在PET/CT上被误诊为恶性瘤的潜力.
报告中中18F-FDG和18F-Choline摄入量增加的病例,这些病例归因于 schwannoma.
强调将成像检测结果与组织病理学相结合的重要性,以准确诊断.

主要方法:

关于两名患有中质块的患者的病例报告.
使用18F-FDG PET/CT和18F-Choline PET/CT进行成像.
用加多增强进行胸部MRI.
诊断的组织病理学确认.

主要成果:

一名70岁的妇女在右后中中显示18F-FDG吸收增加,后来被诊断为神经瘤.
一名患有前列腺癌的66岁男子在右后中间体中显示18F-胆的吸收增加,也被诊断为神经瘤.
胸部MRI显示,在两种情况下都有强烈的gadolinium增强,与 schwannoma 一致.

结论:

介质体中的 Schwannomas 可能会显示18F-FDG和18F-Choline的吸收增加.
这些发现可能导致诊断陷,在PET/CT上模仿恶性疾病.
组织学确认对于区分神经瘤与其他中关节病理是必不可少的.

关键词:

18 F-胆PET/CTCT是一种在FDG-PET/CT中使用.这就是为什么MRI是MRI.前列腺癌是前列腺癌.胸部神经瘤 (Toracic Schwannoma) 是一个严重的疾病.

更多相关视频

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET